United Therapeutics (UTHR) Insider Trading & Ownership $300.43 -1.07 (-0.35%) Closing price 08/11/2025 04:00 PM EasternExtended Trading$296.75 -3.68 (-1.22%) As of 07:00 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock United Therapeutics (NASDAQ:UTHR) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage10.30%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)11Amount OfInsider Selling(Last 12 Months)$132.08M Get UTHR Insider Trade Alerts Want to know when executives and insiders are buying or selling United Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address UTHR Insider Buying and Selling by Quarter United Therapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails8/7/2025Paul A MahonEVPSell11,000$300.00$3,300,000.00 7/24/2025Paul A MahonEVPSell11,000$304.11$3,345,210.00 7/10/2025Paul A MahonEVPSell11,000$300.31$3,303,410.00 6/27/2025Michael T. McCaulU.S. Congress Member (R-TX)Sell$284.27$100,001 - $250,0006/26/2025Paul A MahonEVPSell11,000$285.70$3,142,700.00 6/24/2025Nilda MesaDirectorSell645$289.99$187,043.55 6/24/2025Richard GiltnerDirectorSell3,036$289.60$879,225.60 6/12/2025Paul A MahonEVPSell11,000$279.96$3,079,560.00 6/9/2025James EdgemondCFOSell12,000$325.37$3,904,440.00 5/29/2025Paul A MahonEVPSell11,000$316.07$3,476,770.00 5/1/2025Paul A MahonEVPSell11,000$300.93$3,310,230.00 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 4/21/2025Raymond DwekDirectorSell3,000$285.57$856,710.00 4/17/2025Paul A MahonEVPSell11,000$283.78$3,121,580.00 4/14/2025Raymond DwekDirectorSell3,000$285.16$855,480.00 4/7/2025Raymond DwekDirectorSell4,000$284.55$1,138,200.00 4/3/2025Paul A MahonEVPSell11,000$306.18$3,367,980.00 3/24/2025Tommy G ThompsonDirectorSell2,500$318.80$797,000.00 2/24/2025Michael BenkowitzCOOSell10,000$360.76$3,607,600.00 2/18/2025Michael BenkowitzCOOSell10,000$371.05$3,710,500.00 2/10/2025Michael BenkowitzCOOSell10,000$348.06$3,480,600.00 2/3/2025Michael BenkowitzCOOSell10,000$353.64$3,536,400.00 1/27/2025Michael BenkowitzCOOSell10,000$370.71$3,707,100.00 1/21/2025Michael BenkowitzCOOSell10,000$364.91$3,649,100.00 1/13/2025Michael BenkowitzCOOSell10,000$364.62$3,646,200.00 12/30/2024Michael BenkowitzCOOSell10,000$356.68$3,566,800.00 12/30/2024Nilda MesaDirectorSell255$355.77$90,721.35 12/23/2024Michael BenkowitzCOOSell10,000$361.95$3,619,500.00 12/18/2024Louis W SullivanDirectorSell26,209$373.22$9,781,722.98 12/5/2024Paul A MahonEVPSell7,700$374.37$2,882,649.00 11/25/2024Michael BenkowitzCOOSell10,000$372.75$3,727,500.00 11/21/2024Paul A MahonEVPSell7,700$367.36$2,828,672.00 11/11/2024Judy D OlianDirectorSell1,750$412.48$721,840.00 11/11/2024Michael BenkowitzCOOSell15,000$407.32$6,109,800.00 11/8/2024Nilda MesaDirectorSell224$412.28$92,350.72 11/7/2024Michael BenkowitzCOOSell15,000$401.44$6,021,600.00 11/1/2024Christopher CauseyDirectorSell510$376.63$192,081.30 11/1/2024Michael BenkowitzCOOSell14,700$374.46$5,504,562.00 10/28/2024James EdgemondCFOSell7,800$350.00$2,730,000.00 10/21/2024James EdgemondCFOSell7,782$366.99$2,855,916.18 10/14/2024James EdgemondCFOSell7,792$355.88$2,773,016.96 10/7/2024James EdgemondCFOSell7,794$355.54$2,771,078.76 Trump’s national nightmare is here (Ad)Porter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger the biggest forced rotation of capital since World War II. They reveal why Trump is mobilizing America’s tech giants… and name the two stocks most likely to soar as trillions shift behind the scenes.Watch the National Emergency broadcast here9/30/2024James EdgemondCFOSell7,792$358.62$2,794,367.04 9/23/2024James EdgemondCFOSell7,796$354.04$2,760,095.84 9/9/2024James EdgemondCFOSell7,802$345.41$2,694,888.82 9/3/2024James EdgemondCFOSell7,785$362.37$2,821,050.45 8/26/2024Martine A RothblattCEOSell269$348.41$93,722.29 8/19/2024Martine A RothblattCEOSell3,600$344.18$1,239,048.00 (Data available from 1/1/2013 forward) UTHR Insider Trading Activity - Frequently Asked Questions Who is on United Therapeutics' Insider Roster? The list of insiders at United Therapeutics includes Christopher Causey, Christopher Patusky, James Edgemond, Judy D Olian, Louis W Sullivan, Martine A Rothblatt, Michael Benkowitz, Nilda Mesa, Paul A Mahon, Raymond Dwek, Richard Giltner, and Tommy G Thompson. Learn more on insiders at UTHR. What percentage of United Therapeutics stock is owned by insiders? 10.30% of United Therapeutics stock is owned by insiders. Learn more on UTHR's insider holdings. Which United Therapeutics insiders have been selling company stock? The following insiders have sold UTHR shares in the last 24 months: Christopher Causey ($2,086,379.70), Christopher Patusky ($722,618.50), James Edgemond ($26,104,854.05), Judy D Olian ($721,840.00), Louis W Sullivan ($9,781,722.98), Martine A Rothblatt ($62,573,677.79), Michael Benkowitz ($61,971,762.00), Nilda Mesa ($765,471.28), Paul A Mahon ($52,763,781.00), Raymond Dwek ($4,477,140.00), Richard Giltner ($879,225.60), and Tommy G Thompson ($797,000.00). How much insider selling is happening at United Therapeutics? Insiders have sold a total of 729,903 United Therapeutics shares in the last 24 months for a total of $223,645,472.90 sold. Which members of congress are trading United Therapeutics? Michael T. McCaul (R-TX) has sold shares of United Therapeutics in the last year totaling $175,000. United Therapeutics Key ExecutivesDr. Martine A. Rothblatt J.D. (Age 69)M.B.A., Ph.D., Founder, Chairman & CEO Compensation: $5.66MMr. Michael I. Benkowitz (Age 52)President & COO Compensation: $3.26M2 recent tradesMr. James C. Edgemond (Age 56)CFO & Treasurer Compensation: $2.15M1 recent tradesMr. Paul A. Mahon J.D. (Age 60)Executive VP, General Counsel & Corporate Secretary Compensation: $2.44M9 recent tradesMr. Dewey Steadman C.F.A.Head of Investor RelationsMs. Holly HobsonAssociate Vice President of Human ResourcesKevin T. GraySenior Vice President of Strategic Operations & LogisticsMr. Patrick Poisson (Age 56)Executive VP of Technical Operations Dr. Leigh PetersonExecutive Vice President of Product Development & XenotransplantationMr. Gil GoldenSenior VP & Chief Medical Officer More Insider Trading Tools from MarketBeat Related Companies BIIB Insider Selling INCY Insider Selling NBIX Insider Selling BMRN Insider Selling EXEL Insider Selling EXAS Insider Selling HALO Insider Selling MDGL Insider Selling IONS Insider Selling RGEN Insider Selling Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Strategy Insiders Buy In While Analysts Predict Big UpsideThe Bottom Is in For These 3 Small-Cap Stocks Insiders Are Buying3 Catalysts Driving Plug Power’s Turnaround CaseInsider Selling Hits Market Leaders—Should You Be Worried?Insiders Spent Millions on These 3 Stocks Over the Past 2 Months This page (NASDAQ:UTHR) was last updated on 8/12/2025 by MarketBeat.com Staff From Our PartnersWhen the levee breaksThe U.S. Treasury just confirmed it plans to borrow $1.01 trillion this quarter—nearly double what was project...Porter & Company | SponsoredWhy Elon put $51 million into thisChris Rowe has made legendary calls—Tesla at $13, Nvidia at $40, Bitcoin under $1,000, Amazon at 12 cents. Now...True Market Insiders | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMusk’s Project Colossus could mint millionairesI predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...Brownstone Research | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | SponsoredGenesis 14:13-17 [HIDDEN MEANING?]A mysterious Bible verse from Genesis may hold the key to unlocking what one expert calls an “American birthri...Paradigm Press | SponsoredSell these stocks now—what to buy insteadWall Street veteran Marc Chaikin—creator of the Power Gauge system—is warning that “smart money” is rapidly pu...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding United Therapeutics Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share United Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access